<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neurotherapeutics</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurotherapeutics</journal-id>
<journal-title-group>
<journal-title>Neurotherapeutics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1933-7213</issn>
<issn pub-type="epub">1878-7479</issn>
<publisher>
<publisher-name>Springer US</publisher-name>
<publisher-loc>New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29340928</article-id>
<article-id pub-id-type="pmc">5794708</article-id>
<article-id pub-id-type="publisher-id">598</article-id>
<article-id pub-id-type="doi">10.1007/s13311-017-0598-8</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Microbiota Signaling Pathways that Influence Neurologic Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cox</surname>
<given-names>Laura M.</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Weiner</surname>
<given-names>Howard L.</given-names>
</name>
<address>
<email>hweiner@rics.bwh.harvard.edu</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1">Ann Romney Center for Neurologic Diseases, Brigham &amp; Women’s Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02446 USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>16</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2018</year>
</pub-date>
<volume>15</volume>
<issue>1</issue>
<fpage>135</fpage>
<lpage>145</lpage>
<permissions>
<copyright-statement>© The American Society for Experimental NeuroTherapeutics, Inc. 2018</copyright-statement>
</permissions>
<abstract id="Abs1">
<p id="Par1">Though seemingly distinct and autonomous, emerging evidence suggests there is a bidirectional interaction between the intestinal microbiota and the brain. This crosstalk may play a substantial role in neurologic diseases, including anxiety, depression, autism, multiple sclerosis, Parkinson’s disease, and, potentially, Alzheimer’s disease. Long hypothesized by Metchnikoff and others well over 100 years ago, investigations into the mind–microbe axis is now seeing a rapid resurgence of research. If specific pathways and mechanisms of interaction are understood, it could have broad therapeutic potential, as the microbiome is environmentally acquired and can be modified to promote health. This review will discuss immune, endocrine, and neural system pathways that interconnect the gut microbiota to central nervous system and discuss how these findings might be applied to neurologic disease.</p>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1007/s13311-017-0598-8) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Key Words</title>
<kwd>Microbiome</kwd>
<kwd>immunity</kwd>
<kwd>neuroinflammation</kwd>
<kwd>neurotransmitters</kwd>
<kwd>gastrointestinal tract</kwd>
<kwd>neuroendocrine signaling</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id>
<institution>National Institute of Neurological Disorders and Stroke</institution>
</institution-wrap>
</funding-source>
<award-id>1R01NS087226</award-id>
<principal-award-recipient>
<name>
<surname>Weiner</surname>
<given-names>Howard L.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The American Society for Experimental NeuroTherapeutics, Inc. 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>